Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis

Thrombosis and Haemostasis

Volumn 108, Issue 5, 2012, Pages 973-980

  Krysiak, Robert ^a   Okopien, Boguslaw ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiovascular risk factors; Coagulation; Fibrinolysis; Hashimoto's thyroiditis; Levothyroxine; Selenomethionine

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; LEVOTHYROXINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SELENOMETHIONINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; VON WILLEBRAND FACTOR;

ABDOMINAL PAIN; ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG WITHDRAWAL; EUTHYROIDISM; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HASHIMOTO DISEASE; HEADACHE; HEMOSTASIS; HUMAN; HUMAN CELL; HYPERPARATHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RADIOASSAY; RASH;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BLOOD COAGULATION; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; FIBRINOLYSIS; HASHIMOTO DISEASE; HEMOSTASIS; HEMOSTATIC DISORDERS; HUMANS; LIPIDS; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SELENOMETHIONINE; THYROID HORMONES; THYROXINE; YOUNG ADULT;

EID: 84870379884     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-04-0275     Document Type: Article

References (24)

1. Weetman AP, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev 1994; 15: 788-802.
2. Caturegli P, et al. Autoimmune thyroid diseases. Curr Opin Rheumatol 2007; 19: 44-48.
3. Ichiki T. Thyroid hormone and atherosclerosis. Vascul Pharmacol 2010; 52: 151-156.
4. Owen PJ, et al. Thyroid disease and vascular function. Thyroid 2007; 17: 519-524.
5. Ciccone MM, et al. Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage? BMC Cardiovasc Disord 2010; 10: 22.
6. Stamatelopoulos KS, et al. Arterial stiffness but not intima-media thickness is increased in euthyroid patients with Hashimoto's thyroiditis: The effect of menopausal status. Thyroid 2009; 19: 857-862.
7. Krysiak R, Okopien B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2011; 96: 2206-2215.
8. Franchini M, et al. Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost 2009; 35: 288-294.
9. Vescovi PP, et al. The spectrum of coagulation abnormalities in thyroid disorders. Semin Thromb Hemost 2011; 37: 7-10.
10. Chan MY, et al. Hypercoagulable states in cardiovascular disease. Circulation 2008; 118: 2286-2297.
11. Warkentin TE. Haemostasis and atherosclerosis. Can J Cardiol 1995; 11 (Suppl C): 29C-34C.
12. Kannel WB. Overview of haemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005; 40: 1215-1220.
13. Zaletel K, Gaberšcek S. Hashimoto's thyroiditis: from genes to the disease. Curr Genomics 2011; 12: 576-588.
14. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417-430.
15. Levi M, et al. Infection and inflammation and the coagulation system. Cardiovasc Res 2003; 60: 26-39.
16. Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 2007; 65: S253-259.
17. Dahlback B. Blood coagulation. Lancet 2000; 355: 1627-1632.
18. Asvold BO, et al. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med 2008; 168: 855-860.
19. Lekakis J, et al. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and highnormal serum thyrotropin (TSH) values. Thyroid 1997, 7: 411-414.
20. Takamura N, et al. Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. Atherosclerosis 2009; 204: e77-81.
21. Asvold BO, et al. Association between blood pressure and serum TSH concentration within the reference range: a population-based study. J Clin Endocrinol Metab 2007; 92: 841-845.
22. Park HT, et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 2009; 62: 301-305.
23. Vanderpump MP, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43: 55-68.
24. Klapcinska B, et al. Selenium levels in blood of upper Silesian population: evidence of suboptimal selenium status in a significant percentage of the population. Biol Trace Elem Res 2005; 108: 1-15.